Community Care Rx (CCRx) recently launched its Welcome to CCRx Medication Review Program, a program created to help new members and improve their transition into CCRx's Medicare Part D plan. The outcome elevates the quality of care to beneficiaries through face-to-face meetings with their community pharmacists for a timely review of their drug regimens as they enroll in the prescription drug benefit. The Medication Review Program will be a reimbursable service for pharmacists.
CCRx officials are aware that one-on-one encounters with the patient's pharmacists can be more effective to guarantee clinically appropriate and timely medication transitions. During a Medication Review, community pharmacists will work with CCRx beneficiaries to evaluate their current medication use and make suggestions related to the following:
"We believe that CCRx is taking a gigantic step in the right direction by engaging the services of the community pharmacist to better care for Medicare beneficiaries," said Bruce Roberts, RPh, executive vice president and chief executive officer for the National Community Pharmacists Association. "Community pharmacists are medication experts, and their patients have a high comfort level and trust in them."
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs